Download now
← Case studies
2022-04-24Regulations

510(k) Approval Weeks Ahead of Deadline

Case study on 510(k) Approval Weeks Ahead of Deadline.

Learn how USDM helped expedite the creation of a 510(k) and received FDA approval on the submission.

ARC-One Solutions created a next-generation Blood Establishment Computer Software (BECS) platform to support safe, efficient, and compliant regulated blood supply chain management and required FDA approval of their 510(k).

There is a long list of global regulations and USDM has the experience and expertise to support life sciences companies with their domestic and global submissions.

The Situation
  • ARC-One Solutions, LLC
  • Manufacturer of an FDA 510(k) cleared medical device
  • The customer had a tight 510(k) submission deadline and needed assistance creating the 510(k) body
  • Review of supporting documentation required for the submission
  • The customer wanted to receive clearance from the FDA with minimal questions
The Solution
  • USDM worked with the quality assurance (QA) and regulatory affairs (RA) managers, and the
  • USDM reviewed more than 100 supporting documents for the submission, then drafted the body of the 510(k)
  • FDA clearance was received weeks ahead of customer’s deadline

The Results

  • More than 100 documents reviewed
  • 80 man-hours saved
  • Clearance received weeks before due date​
  • Minimal questions from FDA

“Through a combination of expertise, experience, and excellent customer service, USDM provided the tools we needed to submit for our 510(k) and receive clearance ahead of our schedule.”
-Adam Rosenzweig, General Manager, ARC-One
About ARC-One

ARC-One Solutions, LLC was created in April 2020 through a partnership between two of the largest blood centers in the country, the American Red Cross and OneBlood. ARC-One Solutions has the privilege and responsibility to assist these organizations in fulfilling over 50% of the nation’s blood supply needs. Once implemented, their software will process approximately 10 million products across 56 states and territories.

Start here

Put AI to work in life sciences — with the right guardrails underneath.

Start with a structured AI Readiness Assessment: fixed-fee, executive-ready, and built to surface the highest-value workflows first.

  • Workflow inventory and risk classification
  • Business value and readiness scoring
  • FDA CSA + EU AI Act + ISO 42001 gap analysis
  • Prioritized 90-day roadmap by impact, risk, and effort

Start here

Talk to USDM

Tell us what workflow or outcome you want to improve and we'll map the right AI, governance, and delivery path.

By submitting this form, you agree to USDM’s Privacy Policy and consent to receive communications from USDM. You can unsubscribe at any time using the link in our emails.